KD Logo

Taking a Closer Look At Aurinia Pharmaceuticals Inc (AUPH) Following Its Recent Trade

ZOM Stock

Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on Mar 07 ’25. In the deal valued at $8.23 per share,8,305 shares were sold. As a result of this transaction, Keenan Greg now holds 153,484 shares worth roughly $1.19 million.

Then, Greenleaf Peter sold 195,593 shares, generating $1,564,744 in total proceeds. Upon selling the shares at $8.00, the Chief Executive Officer now owns 1,953,892 shares.

Before that, Greenleaf Peter sold 164,947 shares. Aurinia Pharmaceuticals Inc shares valued at $1,306,380 were divested by the Chief Executive Officer at a price of $7.92 per share. As a result of the transaction, Greenleaf Peter now holds 1,788,945 shares, worth roughly $13.86 million.

Oppenheimer downgraded its Aurinia Pharmaceuticals Inc [AUPH] rating to a Perform from a an Outperform in a research note published recently. Oppenheimer also remained covering AUPH and has increased its forecast on December 10, 2021 with a “an Outperform” recommendation from previously “Perform” rating. Oppenheimer revised its rating on October 28, 2021. It rated AUPH as “a Perform” which previously was an “an Outperform”.

Price Performance Review of AUPH

On Thursday, Aurinia Pharmaceuticals Inc [NASDAQ:AUPH] saw its stock jump 1.04% to $7.75. Over the last five days, the stock has gained 5.59%. Aurinia Pharmaceuticals Inc shares have fallen nearly -13.70% since the year began. Nevertheless, the stocks have risen 55.00% over the past one year. While a 52-week high of $10.67 was reached on 01/02/25, a 52-week low of $4.71 was recorded on 02/27/25. SMA at 50 days reached $8.02, while 200 days put it at $7.50.

Levels Of Support And Resistance For AUPH Stock

The 24-hour chart illustrates a support level at 7.66, which if violated will result in even more drops to 7.58. On the upside, there is a resistance level at 7.80. A further resistance level may holdings at 7.86. The Relative Strength Index (RSI) on the 14-day chart is 46.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 34.04%. Stochastics %K at 57.49% indicates the stock is a holding.

How much short interest is there in Aurinia Pharmaceuticals Inc?

A steep rise in short interest was recorded in Aurinia Pharmaceuticals Inc stocks on 2025-03-31, dropping by 18718.0 shares to a total of 11.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 11.51 million shares. There was a decline of -0.16%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on January 25, 2021 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $35.

Most Popular